The Data Commons has received multiple requests for purposes including novel research, publication validation and grant submission. To date, 37 data requests have been submitted to DAC. Fourteen requests have been formally approved, and 12 requests are pending review or revision. Below is a sample of approved requests from DAC or Report Request Portal.
|PI Name||Project Title|
|Tassiopoulos||COVID-19 and Post Discharge VTE|
|Kalogeropoulos||Improving Cardiac Care in Patients Admitted with SARS-CoV-2 Coronavirus Disease 2019|
|Miller||Beyond BMI, how does obesity influence COVID-19 outcomes?|
|Tassiopoulos||COVID and VTE Post Discharge|
|Khan||Prevalence of Endotoxemia in Hospitalized Patients with COVID-19|
|Ahmad||Characteristics of Pleural Effusion in Severe Acute Respiratory Syndrome (SARS-CoV-2) Infections|
|Ahmad||Statins and COVID-19 Infections|
|Kaplan||Predicting Risk Factors for Hypotension in Severe MIS-C|
|Harwayne-Gidansky||Overcoming COVID-19 — Surveillance Registry Funded by CDCP|
|LaTorre||Role of Early Palliative Care During a Pandemic: Patient Characteristics, Interventions, Impact and Outcome|
|Kaufman||Use of Chest CT and Machine Learning for Diagnosis and Management of COVID-19 Patients|
|Liang||Artificial Intelligence-Enabled Algorithms for Detecting COVID-19 and Predicting Treatment Outcomes|
|Mikell||Prospective Data Collection and Review of COVID-19 Patients: d-Dimer-Driven Anticoagulation|
|Newton||COVID-19 Risk Factor Variation by Patient Ethnicity|
|You||Metabolomics and Proteomics of COVID-19 Patient Plasma|
Industry Sponsored Trials:
SDI-PMX-013 (Clinical Trial) (Mallipattu (PI)) 6/2/20-current
Sponsor: Spectral Medical Inc.&
Title: Evaluating the use of Polymyxin B cartridge hemoperfusion for patients with septic shock and COVID-19.
Goal: The goal of this study is to determine the efficacy of Polymyxin B Hemoperfusion in the treatment of COVID-19.
1 Chaudhri I, Koraishy FM, Bolotova O, Yoo J, Marcos LA, Taub E, Sahib H, Bloom M, Ahmad S, Skopicki H, Mallipattu SK. Outcomes associated with the use of RAAS Blockade in hospitalized patients with SARS-CoV-2 infection. Kidney360 (2020). doi:10.34067/KID.0003792020.
2 Stony Brook COVID-19 Research Consortium. Geospatial Distribution and Predictors of Mortality in Hospitalized Patients with COVID-19: A Cohort Study. Open Forum Infectious Diseases (2020). PMID: 33117852
3 Chaudhri I, Moffit R, Taub E, Annadi R, Hoai M, Bolotova O, Yoo J, Dhaliwal S, Sahib H, Daccueil F, Hajagos J, Saltz M, Saltz J, Mallipattu SK, Koraishy FM. Association of Proteinuria and Hematuria with Acute Kidney Injury and Mortality in Hospitalized Patients with COVID-19. Kidney Blood Pressure Research (2020). PMID: 33171466
4 Khan S, Mallipattu SK*. Repurposing Baby Monitors in Inpatient Dialysis during the COVID19 Pandemic. Kidney Medicine (2020). (In Press)
5 Bolotova O, Yoo J, Chaudhri I, Marcos LA, Sahib H, Koraishy FM, Skopicki H, Ahmad S, Mallipattu SK. Safety, Tolerability, and Efficacy of Losartan in Patients Hospitalized with SARS-CoV-2 Infection: A Feasibility Study. PlosOne (2020). (In Revision)
6 Khan S, Bolotova O, Sahib H, Foster D, Ahmad S, Mallipattu SK. Endotoxemia in Critically Ill Patients with SARS-CoV-2 Infection (2020). Critical Care Medicine (In Revision)